Camp4 Therapeutics (CAMP) Cash from Investing Activities (2023 - 2025)
Camp4 Therapeutics' (CAMP) quarterly Cash from Investing Activities came in at $36000.0 in Q3 2025, up 112.9% quarter-over-quarter from -$279000.0 in Q1 2025.
Camp4 Therapeutics (CAMP) Cash from Investing Activities (2023 - 2025) Analysis & Trends
Camp4 Therapeutics has disclosed Cash from Investing Activities across 3 years of filings, most recently posting $36000.0 for Q3 2025.
- Cash from Investing Activities for Q3 2025 came in at $36000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $36000.0 (up 105.11% YoY), and the FY2025 annual result was -$243000.0, up 44.9% from the prior year.
- Cash from Investing Activities came in at $36000.0 for Q3 2025 at Camp4 Therapeutics, up from -$279000.0 in the prior quarter.
- In the past five years, Cash from Investing Activities ranged from a high of $36000.0 in Q3 2025 to a low of -$279000.0 in Q1 2025.
- The 3-year median for Cash from Investing Activities is -$203000.0 (2023), against an average of -$154500.0.
- Across the five-year window, Cash from Investing Activities slipped 8.23% in 2024 and sank 1760.0% in 2025, its largest moves.
- Camp4 Therapeutics' Cash from Investing Activities stood at -$243000.0 in 2023, then dropped by 8.23% to -$263000.0 in 2024, then jumped by 113.69% to $36000.0 in 2025.
- The last three Cash from Investing Activities figures came in at $36000.0 (Q3 2025), -$279000.0 (Q1 2025), and -$263000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - | -2.89 Mn |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn | 638.50 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn | -431.90 Mn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - | 579,519.10 |
| 10 | Camp4 Therapeutics | 245.02 Mn | 245.02 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 36,000.00 |
| Sep 30, 2025 | 36,000.00 |
| Mar 31, 2025 | -279,000.00 |
| Mar 31, 2025 | -279,000.00 |
| Dec 31, 2024 | -263,000.00 |
| Dec 31, 2024 | -263,000.00 |
| Jun 30, 2024 | -163,000.00 |
| Jun 30, 2024 | -163,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Mar 31, 2024 | -15,000.00 |
| Dec 31, 2023 | -243,000.00 |
| Dec 31, 2023 | -243,000.00 |